Home>Topics>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. Commentary
  3. Fund Reports
  4. ETF Reports
  5. Headlines
  1. Today's Market: Biotech Names Rallying Today

    Headlines

    Wed, 23 Jul 2014

    larger players in the sector by buying ETFs, such as the SPDR S&P Biotech ETF (NY XBI ) and the iShares Nasdaq Biotechnology (NASDAQ: IBB ) with our preference being the SPDR S&P Biotech due to it having less exposure to the more speculative

  2. Physician payment data to be made public on September 30

    Headlines

    Tue, 15 Jul 2014

    for covered recipients. Predictably, medical industry observers are confident that the disclosures will generate substantial interest from a wide swath of the health care sector. ETFs: IBB , BIB , IRY , IXJ , BIS , DRGS Post your comment!

  3. Fed report depresses biotechs

    Headlines

    Tue, 15 Jul 2014

    Biotech shares retreat today as the group continues its downtrend that started on July 7. Shares of ( IBB -1.8% ) are down ~5% from July 3's peak of $266.43. Contributing to the sell-off is the Federal Reserve's Monetary

  4. Yellen warns on small cap and momo sector valuations

    Headlines

    Tue, 15 Jul 2014

    remain little-changed. Small caps ( IWM -0.7% ) and momentum sectors like social media ( SOCL -1.1% ) and biotech ( IBB -1.1% ) are selling off as the Fed boss says their valuations "appear to be stretched." The Q&A is underway; live blog

  5. Ebola outbreak in West Africa uncontained

    Headlines

    Fri, 11 Jul 2014

    mortality rate is as high as 90%. It is spread by close contact with the body fluids and tissues of infected people. There is no treatment or vaccine available. ETFs: BBRC , EMBB ETFs: IBB , BIB , IRY , IXJ , BIS , DRGS Post your comment!

  6. Pros And Cons Of Tactical Allocation Explained With A Real Trade

    Headlines

    Thu, 10 Jul 2014

    portfolio. This one illustrates the pros and cons of tactical allocation with a former holding: the iShares Nasdaq Biotechnology ETF ( IBB ). It is just an example; however, this trade is quite typical of the pros and cons of tactical allocation

  7. Omega Pharma reportedly mulling sale

    Headlines

    Mon, 7 Jul 2014

    Bloomberg reports that privately-held Omega Pharma N.V. is exploring a sale of the company for as much as $4B. The Belgian firm was taken private ~three years ago by the founder. ETFs: IBB , BIB , IRY , IXJ , BIS , EWK , DRGS Post your comment!

  8. Basket Of Biotech Bargains To Buy And Hold

    Headlines

    Mon, 30 Jun 2014

    Gilead ( GILD ). So when it looked like the stampede out of biotech might be over, I parked my cash in iShares NASDAQ Biotechnology ETF ( IBB ) and Fidelity Select Biotechnology Portfolio (FBIOX). Now that these repositories have recovered

  9. New Issue- IBB prices 55 mln euro 2021 bond

    Headlines

    Mon, 30 Jun 2014

    For news about this issuer, double click on the issuer RIC,

  10. Islamic Bank of Britain eyes new business, break-even -CEO

    Headlines

    Tue, 24 Jun 2014

    June 24 (Reuters) - Islamic Bank of Britain ( IBB ), the country's only sharia-compliant retail lender, plans to broaden its product range to win business both locally and across Europe, aided by the...

« Prev1234Next »
Content Partners